The Influence of Stereotype Threat and Implicit Theories of Emotion on Gender Differences in Emotional Intelligence

2020 ◽  
pp. 106082652092087
Author(s):  
Randi A. Doyle ◽  
Ashley E. Thompson

The current study investigated the effects of stereotype threat on emotional intelligence (EI) performance and the utility of implicit theories of emotion (ITE; fixed/growth mind-set) to reduce stereotype threat effects. In Experiment 1, 186 adults received one of four EI stereotype conditions (threat, boost, nullified threat, and control) and then completed measures of ability-based EI and ITE. The results revealed that women outperform men in the “threat to men” and control conditions and that ITE moderated this gender difference. In the nullified threat condition, men with a growth mind-set outperformed men with a fixed mind-set. In Experiment 2, EI stereotypes and ITE were manipulated. The results from 452 adults indicated that the ITE manipulation affected men’s EI performance but not women’s. Overall, men adopting a growth mind-set demonstrated trends in which they outperformed men adopting a fixed mind-set. Implications related to the reduction of gender disparities in EI performance are discussed.

2012 ◽  
Vol 220 (2) ◽  
pp. 70-77 ◽  
Author(s):  
Marco Hirnstein ◽  
Nadja Freund ◽  
Markus Hausmann

Numerous studies have demonstrated that fear of confirming negative stereotypes (stereotype threat) can hamper women’s performance in certain mathematical and spatial tasks in which men usually excel. By contrast, very little is known about how men are affected by stereotype threat in tasks in which women excel. We therefore asked 36 men and 39 women, recruited at the Ruhr-University of Bochum, Germany, to complete two tests of verbal fluency (word fluency, four-word sentences). Prior to testing, participants were either told that gender differences in verbal abilities were going to be investigated or they received gender-neutral task instructions. We hypothesized that this would trigger the gender stereotype of women’s verbal superiority and, as a consequence, lead to a stereotype threat effect with decreased verbal fluency performance in men. However, men’s verbal fluency scores were higher under gender difference instructions than in the control condition. Since women showed a similar pattern and had generally higher scores, the gender difference remained stable across conditions. The findings may reflect (a) that gender stereotyping induced a competitive situation and, as a result, enhanced performance in all participants or (b) stereotype reactance in men, which would suggest that men and women react differently to gender stereotype activations in gender-sensitive cognitive abilities. Either way, the findings imply that cognitive performance changes significantly if participants are aware that cognitive gender differences are investigated, which is probably the case in many studies investigating gender differences.


2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Ailiana Santosa ◽  
Yue Zhang ◽  
Lars Weinehall ◽  
Genming Zhao ◽  
Na Wang ◽  
...  

An amendment to this paper has been published and can be accessed via the original article.


2021 ◽  
Vol 80 (Suppl 1) ◽  
pp. 320.1-321
Author(s):  
E. Loibner ◽  
V. Ritschl ◽  
B. Leeb ◽  
P. Spellitz ◽  
G. Eichbauer-Sturm ◽  
...  

Background:Gender differences in prevalence and disease course are known in various rheumatic diseases; however, investigations of gender difference concerning therapeutical response have yielded variable results.Objectives:The aim of this retrospective study was to investigate, whether a gender difference in response rate to biological disease-modifying antirheumatic drugs (bDMARDs) and apremilast in bDMARD-naïve patients could be observed across the three most prevalent inflammatory arthritis diseases: rheumatoid arthritis (RA), spondylarthritis (SpA) and psoriatic arthritis (PsA). Additionally, a response to individual TNF blockers was investigated in this respect.Methods:Data from bDMARD-naïve RA-, SpA- and PsA-patients from Bioreg, the Austrian registry for biological DMARDs in rheumatic diseases, were used. Patients with a baseline (Visit 1=V1) and follow-up visits at 6 months (Visit 2=V2) and 12 months (Visit 3=V3) were included and response to therapy with TNF-inhibitors (TNFi), furthermore to therapy with rituximab, tocilizumab and apremilast was analyzed according to gender. The remaining bDMARDs were not analyzed due to small numbers. Key response-parameter for RA was disease activity score (DAS28), whereas for PsoA the Stockerau Activity Score for Psoriatic Arthritis (SASPA) and for SpA the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) were employed; in addition, the Health assessment Questionnaire (HAQ) was used. Data were analyzed in R Statistic stratified by gender using Kruskal-Wallis and Wilcoxon tests.Results:354 women and 123 men with RA (n=477), 81 women and 69 men with PsA (n=150), 121 women and 191 men with SpA (n=312) were included. No significant differences in biometrics was seen between female and male patients at baseline in all diseases.In RA patients overall DAS28 decreased from baseline (V1) to V2 and V3 (DAS28: V1: male: 4.38 [3.66, 5.11], female: 4.30 [3.68, 5.03], p(m/f) = 0.905; V2: male: 2.66 [1.73, 3.63], female: 3.10 [2.17, 3.98], p(m/f) = 0.015; V3: male: 2.25 [1.39, 3.36], female: 3.01 [1.87, 3.87], p(m/f) = 0.002). For TNF inhibitors (n=311), there was a significant difference between genders at V2 (Fig.1a). Patients receiving Rituximab (n=41) displayed a significantly higher DAS28 at baseline in females, which diminished in the follow up: V1: (p(m/f) p=0.002; V2: p=0.019; V3: p=0.13); response to tocilizumab (n=63) did not show any gender differences.In PsA patients overall SASPA decreased from baseline (V1) to V2 and V3 (SASPA: V1: male: 4.00 [2.80, 5.20], female: 4.40 [2.80, 5.80], p(m/f) = 0.399; V2: male: 2.20 [1.20, 3.50], female: 3.40 [2.00, 5.00], p(m/f) = 0.071; V3: male: 1.80 [0.80, 2.70], female: 3.01 [2.35, 4.80], p(m/f) = 0.001). For TNF inhibitors (n=79), there was a significant difference between genders at V3 (Fig 1a). For Apremilast (n=39), there was a significant difference between genders at V2 (Fig.1c).In SpA patients overall BASDAI decreased from baseline (V1) to V2 and V3 (BASDAI: V1: male: 4.70 [2.88, 6.18], female: 4.80 [3.30, 6.20], p(m/f) = 0.463; V2: male: 3.05 [2.00, 4.60], female: 3.64 [2.62, 5.41], p(m/f) = 0.039; V3: male: 3.02 [1.67, 4.20], female: 3.65 [2.18, 5.47], p(m/f) = 0.016). In V3 a differential BASDAI in response to TNFi (n=299) was observed (Fig.1a).Possible differences of response to individual TNFi (etanercept, infliximab, other TNFi) measured by HAQ were investigated in all diseases together. The difference between male and females was significant at baseline for all 3 TNFi; whereas with the use of ETA the significant difference was carried through to V2 and V3, it was lost with the use of IFX and was variable with the other TNFi (Fig.1b)Figure 1.Conclusion:Female patients showed a statistically lower response to TNFi in all three disease entities (RA, SpA and PsoA) to a variable degree in our homogenous central european population. Interestingly, the difference was not uniform across individual TNFi when measured by HAQ. Gender differences were also seen in response to Apremilast.Disclosure of Interests:Elisabeth Loibner: None declared, Valentin Ritschl: None declared, Burkhard Leeb Speakers bureau: AbbVie, Roche, MSD, Pfizer, Actiopharm, Boehringer-Ingelheim, Kwizda, Celgene, Sandoz, Grünenthal, Eli-Lilly, Grant/research support from: TRB, Roche, Consultancies: AbbVie, Amgen, Roche, MSD, Pfizer, Celgene, Grünenthal, Kwizda, Eli-Lilly, Novartis, Sandoz;, Peter Spellitz: None declared, Gabriela Eichbauer-Sturm: None declared, Jochen Zwerina: None declared, Manfred Herold: None declared, Miriam Stetter: None declared, Rudolf Puchner Speakers bureau: AbbVie, BMS, Janssen, Kwizda, MSD, Pfizer, Celgene, Grünenthal, Eli-Lilly, Consultant of: AbbVie, Amgen, Pfizer, Celgene, Grünenthal, Eli-Lilly, Franz Singer: None declared, Ruth Fritsch-Stork: None declared


2021 ◽  
Vol 35 (1) ◽  
pp. 45-50
Author(s):  
Mona El-Hout ◽  
Alexandra Garr-Schultz ◽  
Sapna Cheryan

Gender disparities in participation in many STEM fields, particularly computer science, engineering, and physics, remain prevalent in Western societies. Stewart-Williams and Halsey contend that an important contributor to these disparities is gender differences in career-related preferences that are driven partly by biology. We argue that Stewart-Williams and Halsey understate the influence of cultural factors in shaping these preferences. We provide evidence for an important and overlooked cultural factor that contributes to gender disparities in computer science, engineering, and physics: masculine defaults. Masculine defaults exist when cultures value and reward traits and characteristics associated with the male gender role and see them as standard ( Cheryan & Markus, 2020 ). We provide examples of how changing computer science, engineering, and physics cultures can decrease gender disparities in participation. Finally, we discuss policy implications, specifically the importance of (1) recognizing that preferences for STEM are malleable and (2) addressing exclusionary cultures of STEM fields. Recognizing and changing exclusionary STEM cultures are important for creating a society that is more just and equitable.


2020 ◽  
Vol 0 (0) ◽  
Author(s):  
Tarek Jaber-Lopez ◽  
Alexandra Baier ◽  
Brent J. Davis

AbstractWe examine gender differences when eliciting distributional preferences as conducted by the Equality Equivalence Test, which has the ability to classify subjects into preferences types. Preferences are elicited when individuals interact with an individual of the same gender and with an individual of the opposite gender. We find elicited preferences are robust across both in-group (same gender) and out-group (opposite gender) interactions. When analyzing the intensity of benevolence (or malevolence) we find that overall women exhibit more malevolence than men, but there is no gender difference for benevolence. Furthermore, women exhibit a higher level of in-group favoritism than men.


2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Ailiana Santosa ◽  
Yue Zhang ◽  
Lars Weinehall ◽  
Genming Zhao ◽  
Na Wang ◽  
...  

Abstract Background Failure to promote early detection and better management of hypertension will contribute to the increasing burden of cardiovascular diseases. This study aims to assess the gender differences in the prevalence, awareness, treatment and control of hypertension, together with its associated factors, in China and Sweden. Methods We used data from two cross-sectional studies: the Västerbotten Intervention Program in northern Sweden (n = 25,511) and the Shanghai survey in eastern China (n = 25,356). We employed multivariable logistic regression to examine the socio-demographics, lifestyle behaviours, and biological factors associated with the prevalence, awareness, treatment and control of hypertension. Results Men had a higher prevalence of hypertension (43% in Sweden, 39% in China) than their female counterparts (29 and 36%, respectively). In Sweden, men were less aware of, less treated for, and had less control over their hypertension than women. Chinese men were more aware of, had similar levels of treatment for, and had less control over their hypertension compared to women. Awareness and control of hypertension was lower in China compared to Sweden. Only 33 and 38% of hypertensive Chinese men and women who were treated reached the treatment goals, compared with a respective 48 and 59% in Sweden. Old age, impaired glucose tolerance or diabetes, a family history of hypertension or cardiovascular diseases, low physical activity and overweight or obesity were found to increase the odds of hypertension and its diagnosis. Conclusions This study shows the age and gender differences in the prevalence, awareness, treatment and control of hypertension among adults in China and Sweden. Multisectoral intervention should be developed to address the increasing burden of sedentary lifestyle, overweight and obesity and diabetes, all of which are linked to the prevention and control of hypertension. Development and implementation of the gender- and context-specific intervention for the prevention and control of hypertension facilitates understanding with regard to the implementation barriers and facilitators.


Life ◽  
2021 ◽  
Vol 11 (6) ◽  
pp. 569
Author(s):  
Liqin Deng ◽  
Xini Zhang ◽  
Songlin Xiao ◽  
Baofeng Wang ◽  
Weijie Fu

This study aims to explore whether gender differences exist in the architectural and mechanical properties of the medial gastrocnemius–Achilles tendon unit (gMTU) in vivo. Thirty-six healthy male and female adults without training experience and regular exercise habits were recruited. The architectural and mechanical properties of the gMTU were measured via an ultrasonography system and MyotonPRO, respectively. Independent t-tests were utilized to quantify the gender difference in the architectural and mechanical properties of the gMTU. In terms of architectural properties, the medial gastrocnemius (MG)’s pennation angle and thickness were greater in males than in females, whereas no substantial gender difference was observed in the MG’s fascicle length; the males possessed Achilles tendons (ATs) with a longer length and a greater cross-sectional area than females. In terms of mechanical properties, the MG’s vertical stiffness was lower and the MG’s logarithmic decrement was greater in females than in males. Both genders had no remarkable difference in the AT’s vertical stiffness and logarithmic decrement. Gender differences of individuals without training experience and regular exercise habits exist in the architectural and mechanical properties of the gMTU in vivo. The MG’s force-producing capacities, ankle torque, mechanical efficiency and peak power were higher in males than in females. The load-resisting capacities of AT were greater and the MG strain was lesser in males than in females. These findings suggest that males have better physical fitness, speed and performance in power-based sports events than females from the perspective of morphology and biomechanics.


2014 ◽  
Vol 22 (1) ◽  
pp. 32-42 ◽  
Author(s):  
Christopher B O’Connell

Background: Nursing practice is complex, as nurses are challenged by increasingly intricate moral and ethical judgments. Inadequately studied in underrepresented groups in nursing, moral distress is a serious problem internationally for healthcare professionals with deleterious effects to patients, nurses, and organizations. Moral distress among nurses has been shown to contribute to decreased job satisfaction and increased turnover, withdrawal from patients, physical and psychological symptoms, and intent to leave current position or to leave the profession altogether. Research question: Do significant gender differences exist in the moral distress scores of critical care nurses? Research design: This study utilized a quantitative, descriptive methodology to explore moral distress levels in a sample of critical care nurses to determine whether gender differences exist in their mean moral distress scores. Participants and research context: Participants ( n = 31) were critical care nurses from an American Internet nursing community who completed the Moral Distress Scale–Revised online over a 5-day period in July 2013. Ethical considerations: Institutional review board review approved the study, and accessing and completing the survey implied informed consent. Findings: The results revealed a statistically significant gender difference in the mean moral distress scores of participants. Females reported statistically significantly higher moral distress scores than did males. Overall, the moral distress scores for both groups were relatively low. Discussion: The findings of a gender difference have not previously been reported in the literature. However, other findings are consistent with previous studies on moral distress. Conclusion: Although the results of this study are not generalizable, they do suggest the need for continuing research on moral distress in underrepresented groups in nursing, including cultural and ethnic groups.


2017 ◽  
Vol 23 (7) ◽  
pp. 577-583 ◽  
Author(s):  
Beatrice Frajo-Apor ◽  
Georg Kemmler ◽  
Silvia Pardeller ◽  
Markus Huber ◽  
Christian Macina ◽  
...  

AbstractObjectives:Social cognitive deficits have been discussed to be endophenotypes for schizophrenia and other serious mental illnesses. The current study aimed to assess emotional intelligence (EI) in unaffected siblings of schizophrenia patients to investigate its potential role as endophenotype for schizophrenia.Methods:EI was measured in 56 schizophrenia patients, 57 unaffected siblings, and 127 healthy control subjects by using the Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT). In addition, non-social cognition was assessed with the Brief Assessment of Cognition in Schizophrenia (BACS). Linear mixed models with compound symmetric correlation structure were used for of the three groups with respect to EI and non-social cognition.Results:Schizophrenia patients showed significantly lower overall EI and performed significantly worse in three out of four MSCEIT branches compared to unaffected siblings and control subjects, whereas the two latter groups had comparable EI levels. Similar performance patterns (patients<unaffected siblings=control subjects) were found with respect to non-social cognition. Solely in the “Tower of London” test, siblings achieved significantly lower task scores compared to control subjects.Conclusions:Based on our results, EI as measured with the MSCEIT does not seem to represent a marker of risk for schizophrenia. Further investigations should concentrate on other EI measures to reassess this finding. (JINS, 2017,23, 577–583)


Sign in / Sign up

Export Citation Format

Share Document